招聘
岗位职责:
- 负责从接收海外客户PO转内部销售订单(SAP SO)至最终发运的端到端操作,确保订单信息流与物流无缝衔接;
- 负责国内物流发运计划的统筹安排并及时传递至仓库备货,负责与客服对接信息等相关事宜;
- 负责跟踪货物在途状态,处理运输异常(如温控偏差、延迟等),及时启动应急预案并记录;如对质量产生影 响,及时上报并启动偏差;
- 负责物流相关的审计响应、风险评估及事件调查工作;
- 负责系统维护发运记录,包括但不限于温度监控数据、运输轨迹、签收凭证及链中断(COT)验证文件,确保符合GCP/GMP法规要求;
- 负责对接临床运营、质量管理(QA)及临床研究中心(Site),快速响应临床发运、反向物流(药品回收/销毁)等特殊需求;
- 基于业务发展和法规变化,主导SOP的制定、更新与培训,提升团队操作效率与风险防控能力;
- 根据业务需求安排的其他相关工作。
任职要求:
- 5年以上国内外物流操作经验;
- 熟悉生物制品及温控产品发运流程;
- 熟悉海运/空运/陆运操作流程,具备报关、报检及单证实务经验者更佳;
- 熟悉国际贸易术语(如EXW、FCA、CIP、DAP等)及海关监管政策;
- 熟练使用物流管理系统及Office办公软件(Excel数据分析能力突出);
- 英语口语能作为工作语言进行业务沟通。
总浏览量
0
申请点击数
0
模拟申请者数
0
收藏
0
相似职位

SPSR
Johnson & Johnson · Wenzhou, Zhejiang, China

Material Handler II
Thermo Fisher · Jiangsu, China

Expert - OFR
DHL · Chengdu, Sichuan, China, People's Republic of

Transportation Specialist - Transportation, NOC Outbound
Amazon · Dalian, 21, CHN

Quality Control Verifier (Destination Inspection)
Mars · CHN-Shanghai-Shanghai
关于BioNTech

BioNTech
PublicBioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
1,001-5,000
员工数
Mainz that develops immunotherapies
总部位置
$21.7B
企业估值
评价
4.0
10条评价
工作生活平衡
2.5
薪酬
3.8
企业文化
4.2
职业发展
3.5
管理层
3.2
75%
推荐给朋友
优点
Innovative and cutting-edge projects
Great team and collaborative environment
Excellent benefits and flexible schedule
缺点
Long working hours and high workload
Fast-paced and high-pressure environment
Management and communication issues
薪资范围
70个数据点
L2
L3
L4
L5
L6
Mid/L4
Intern
L2 · Data Scientist L2
0份报告
$53,767
年薪总额
基本工资
$21,507
股票
$26,884
奖金
$5,377
$37,637
$69,897
面试经验
1次面试
难度
3.0
/ 5
时长
14-28周
面试流程
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Final Interview
6
Offer
常见问题
Behavioral/STAR
Technical Knowledge
Past Experience
Culture Fit
Problem Solving
新闻动态
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
Oncodaily
News
·
1d ago
BioNTech And Boehringer Trial Adds Dimension To Small Cell Lung Cancer Story - simplywall.st
simplywall.st
News
·
3d ago
Biontech prepares FDA application after strong phase II results in endometrial cancer - medwatch.com
medwatch.com
News
·
6d ago
BioNTech and DualityBio report positive data for trastuzumab pamirtecan - Clinical Trials Arena
Clinical Trials Arena
News
·
6d ago